Dimebon improves cognitive function in people with mild to moderate Alzheimer's disease COMMENT

被引：4
|
作者：
Gauthier, Serge [1 ]
机构：
[1] Douglas Mental Hlth Univ Inst, McGill Ctr Studies Aging, Montreal, PQ, Canada
来源：
EVIDENCE-BASED MENTAL HEALTH | 2009年 / 12卷 / 01期
关键词：
D O I：
10.1136/ebmh.12.1.21
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [11] Cognitive and affective Theory of Mind in mild to moderate Alzheimer's disease
    Laisney, Mickael
    Bon, Laetitia
    Guiziou, Catherine
    Daluzeau, Nathalie
    Eustache, Francis
    Desgranges, Beatrice
    JOURNAL OF NEUROPSYCHOLOGY, 2013, 7 (01) : 107 - 120
  • [12] Galantamine improves non-cognitive symptoms as compared to nootropics in outpatients with mild to moderate Alzheimer's disease
    Ibach, B.
    Kuehn, F.
    Gerwe, M.
    Diekamp, B.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 224 - 224
  • [13] Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer’s disease
    Mehmet Yuruyen
    Fundan Engin Akcan
    Gizem Cetiner Batun
    Gozde Gultekin
    Mesut Toprak
    Hakan Yavuzer
    Murat Emul
    Aging Clinical and Experimental Research, 2017, 29 : 1105 - 1111
  • [14] Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer's disease
    Yuruyen, Mehmet
    Akcan, Fundan Engin
    Batun, Gizem Cetiner
    Gultekin, Gozde
    Toprak, Mesut
    Yavuzer, Hakan
    Emul, Murat
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 29 (06) : 1105 - 1111
  • [15] Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
    Bahar-Fuchs, Alex
    Clare, Linda
    Woods, Bob
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [16] Response to "Relationship between sarcopenic obesity and cognitive function in patients with mild to moderate Alzheimer's disease"
    Wei, Lien-Chung
    PSYCHOGERIATRICS, 2023, 23 (06) : 1094 - 1095
  • [17] Dimebon Improves Cognition, Function, and Behavior in Patients With Mild or Moderate Alzheimer's Disease: Results by Disease Severity of a 1-Year Double-Blind, Placebo-Controlled Trial.
    Doody, R.
    Sano, M.
    Aisen, P.
    Seely, L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S122 - S123
  • [18] Diagnostic Validity of the Alzheimer's Disease Functional Assessment and Change Scale in Mild Cognitive Impairment and Mild to Moderate Alzheimer's Disease
    Manero, R. M.
    Casals-Coll, M.
    Sanchez-Benavides, G.
    Rodriguez-de los Reyes, O. N.
    Aguilar, M.
    Badenes, D.
    Molinuevo, J. L.
    Robles, A.
    Barquero, M. S.
    Antunez, C.
    Martinez-Parra, C.
    Frank-Garcia, A.
    Fernandez, M.
    Blesa, R.
    Pena-Casanova, J.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2014, 37 (5-6) : 366 - 375
  • [19] Dimebon improves memory, orientation, language, and praxis in patients with mild to moderate Alzheimer's disease: Results of a one-year placebo-controlled study
    Ferris, Steuen
    Doody, Rochelle
    Gaurilova, Svetlana
    Sano, Mary
    Aisen, Paul
    Seely, Lynn
    NEUROLOGY, 2008, 70 (11) : A393 - A394
  • [20] Differences in Finger Dexterity in Patients With Mild and Moderate Alzheimer's Disease-A Study of Cognitive Function by Disease Severity
    Suzumura, Shota
    Osawa, Aiko
    Sugioka, Junpei
    Kamiya, Masaki
    Sano, Yuko
    Kandori, Akihiko
    Mizuguchi, Tomohiko
    Uchida, Yoshiharu
    Kagaya, Hitoshi
    Kondo, Izumi
    BRAIN AND BEHAVIOR, 2025, 15 (03):
12345